NEWS

Announcement of Investment in Curreio, Inc.

At the Board of Directors meeting held on March 22nd , 2023, we decided to take part of the preferred stock of Curreio, Inc. in connection with the company’s financing of the capital increase.

 

Company description:

  1. Company name: Curreio Inc.
  2. Headquarter: Room 357, South Clinical Research Laboratory, Tokyo University, 7-3-1, Hongo, Bunkyo-ku, TokyoJAPAN
  3. Representative: Motoki Nakai, CEO
  4. Business: Drug discovery and R & D business based on structural analysis using Cryo-EM
  5. Founded: August 2019